VIICTR
Profiles
ORIT
Pediatrics CRA
Home
About
Overview
Sharing Data
ORCID
Help
History (1)
A phase I, open-label, multi-center study of the JAK2 inhibitor AZD1480 in patients with myelofibrosis.
See All Pages
Find People
Find Everything
Login
to edit your profile (add a photo, awards, links to other websites, etc.)
Edit My Profile
My Person List (
0
)
Return to Top
A phase I, open-label, multi-center study of the JAK2 inhibitor AZD1480 in patients with myelofibrosis.
A phase I, open-label, multi-center study of the JAK2 inhibitor AZD1480 in patients with myelofibrosis. Leuk Res. 2015 Feb; 39(2):157-63.
View in:
PubMed
subject areas
Aged
Aged, 80 and over
Anemia
Dizziness
Female
Humans
Janus Kinase 2
Male
Middle Aged
Primary Myelofibrosis
Pyrazoles
Pyrimidines
authors with profiles
HAGOP M KANTARJIAN
SRDAN VERSTOVSEK
JORGE E CORTES